United States · Bill · HR
H.R. 1839 (118th)
Combating Illicit Xylazine Act
Introduced
28 March 2023
Last action
7 April 2023 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Panetta, Jimmy [D-CA-19], Rep. Pfluger, August [R-TX-11], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Buck, Ken [R-CO-4], Rep. Pappas, Chris [D-NH-1], Rep. Bacon, Don [R-NE-2], Rep. Lamborn, Doug [R-CO-5], Rep. Vasquez, Gabe [D-NM-2], Rep. Thompson, Mike [D-CA-4], Rep. Houlahan, Chrissy [D-PA-6], Rep. Trone, David J. [D-MD-6], Rep. Kuster, Ann M. [D-NH-2], Rep. Cline, Ben [R-VA-6], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Nunn, Zachary [R-IA-3], Rep. Harder, Josh [D-CA-9], Rep. Trahan, Lori [D-MA-3], Rep. Kean, Thomas H. [R-NJ-7], Rep. Craig, Angie [D-MN-2], Rep. Norcross, Donald [D-NJ-1], Rep. Quigley, Mike [D-IL-5], Rep. Perez, Marie Gluesenkamp [D-WA-3], Rep. Evans, Dwight [D-PA-3], Yadira Caraveo, Rescom. González-Colón, Jenniffer [R-PR-At Large], Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Cohen, Steve [D-TN-9], Rep. Harris, Andy [R-MD-1], Rep. Ross, Deborah K. [D-NC-2], Lori Chavez-DeRemer, Rep. Wenstrup, Brad R. [R-OH-2], Mike Garcia, Rep. Correa, J. Luis [D-CA-46], Rep. Budzinski, Nikki [D-IL-13], Rep. Norman, Ralph [R-SC-5], Rep. Wild, Susan [D-PA-7], Rep. Neguse, Joe [D-CO-2], Rep. Manning, Kathy E. [D-NC-6], Rep. Clarke, Yvette D. [D-NY-9], Rep. Matsui, Doris O. [D-CA-7], Rep. Bean, Aaron [R-FL-4], Rep. Swalwell, Eric [D-CA-15], Rep. Lucas, Frank D. [R-OK-3], Rep. Dean, Madeleine [D-PA-4], Rep. Mann, Tracey [R-KS-1], Rep. Crenshaw, Dan [R-TX-2], Rep. Harshbarger, Diana [R-TN-1]
Subjects
Discovery layer
Source updated
5 December 2025
Summary
Combating Illicit Xylazine Act This bill criminalizes the illicit use of xylazine. (Xylazine, also known as Tranq , is a sedative that is approved for use in animals. The Drug Enforcement Administration (DEA) has reported an increase in the trafficking of fentanyl mixed with xylazine.) Specifically, the bill establishes criminal penalties for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense, xylazine for illicit use (i.e., for use in humans) in accordance with the penalties for schedule III substances (up to 10 years imprisonment or, if death or serious bodily injury occurs, up to 15 years imprisonment, as well as criminal fines). In addition, the DEA must coordinate with the Food and Drug Administration to report on the prevalence of the illicit use of xylazine, including associated supply chains. The bill also declares the illicit use of xylazine as an emerging drug threat.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
28 March 2023
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
28 March 2023
Introduced
Introduced in House
Source: IntroReferral
28 March 2023
Introduced
Introduced in House
Source: IntroReferral
7 April 2023
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 28 March 2023 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 28 March 2023
Introduced in House (PDF)
Introduced in House · EN · 28 March 2023
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 28 March 2023
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Panetta, Jimmy [D-CA-19] · D · Sponsor
- Rep. Pfluger, August [R-TX-11] · R · Sponsor
- Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
- Rep. Buck, Ken [R-CO-4] · R · Sponsor
- Rep. Pappas, Chris [D-NH-1] · D · Sponsor
- Rep. Bacon, Don [R-NE-2] · R · Sponsor
- Rep. Lamborn, Doug [R-CO-5] · R · Sponsor
- Rep. Vasquez, Gabe [D-NM-2] · D · Sponsor
- Rep. Thompson, Mike [D-CA-4] · D · Sponsor
- Rep. Houlahan, Chrissy [D-PA-6] · D · Sponsor
- Rep. Trone, David J. [D-MD-6] · D · Cosponsor
- Rep. Kuster, Ann M. [D-NH-2] · D · Cosponsor
- Rep. Cline, Ben [R-VA-6] · R · Cosponsor
- Rep. Van Drew, Jefferson [R-NJ-2] · R · Cosponsor
- Rep. Fitzpatrick, Brian K. [R-PA-1] · R · Cosponsor
- Rep. Nunn, Zachary [R-IA-3] · R · Cosponsor
- Rep. Harder, Josh [D-CA-9] · D · Cosponsor
- Rep. Trahan, Lori [D-MA-3] · D · Cosponsor
- Rep. Kean, Thomas H. [R-NJ-7] · R · Cosponsor
- Rep. Craig, Angie [D-MN-2] · D · Cosponsor
- Rep. Norcross, Donald [D-NJ-1] · D · Cosponsor
- Rep. Quigley, Mike [D-IL-5] · D · Cosponsor
- Rep. Perez, Marie Gluesenkamp [D-WA-3] · D · Cosponsor
- Rep. Evans, Dwight [D-PA-3] · D · Cosponsor
- Yadira Caraveo · D · Cosponsor
- Rescom. González-Colón, Jenniffer [R-PR-At Large] · R · Cosponsor
- Rep. Spanberger, Abigail Davis [D-VA-7] · D · Cosponsor
- Rep. Cohen, Steve [D-TN-9] · D · Cosponsor
- Rep. Harris, Andy [R-MD-1] · R · Cosponsor
- Rep. Ross, Deborah K. [D-NC-2] · D · Cosponsor
- Lori Chavez-DeRemer · R · Cosponsor
- Rep. Wenstrup, Brad R. [R-OH-2] · R · Cosponsor
- Mike Garcia · R · Cosponsor
- Rep. Correa, J. Luis [D-CA-46] · D · Cosponsor
- Rep. Budzinski, Nikki [D-IL-13] · D · Cosponsor
- Rep. Norman, Ralph [R-SC-5] · R · Cosponsor
- Rep. Wild, Susan [D-PA-7] · D · Cosponsor
- Rep. Neguse, Joe [D-CO-2] · D · Cosponsor
- Rep. Manning, Kathy E. [D-NC-6] · D · Cosponsor
- Rep. Clarke, Yvette D. [D-NY-9] · D · Cosponsor
- Rep. Matsui, Doris O. [D-CA-7] · D · Cosponsor
- Rep. Bean, Aaron [R-FL-4] · R · Cosponsor
- Rep. Swalwell, Eric [D-CA-15] · D · Cosponsor
- Rep. Lucas, Frank D. [R-OK-3] · R · Cosponsor
- Rep. Dean, Madeleine [D-PA-4] · D · Cosponsor
- Rep. Mann, Tracey [R-KS-1] · R · Cosponsor
- Rep. Crenshaw, Dan [R-TX-2] · R · Cosponsor
- Rep. Harshbarger, Diana [R-TN-1] · R · Cosponsor
Showing 48 of 104 sponsors and actors.
Related records
- related to ← Combating Illicit Xylazine Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/1839
- Open data entity: https://api.congress.gov/v3/bill/118/hr/1839
- us · 118-hr-1839 · source updated 5 December 2025